 2c. Pharmacology. Test whether the post-levodopa changes in WM-related fMRI signal relate specifically to levodopa plasma concentration rather than practice effects, placebo effects, or passage of time and are replicated by a nonselective dopamine receptor agonist or by a dopamine D2D3D4 agonist. 